CCL14, identified by multi-omics approach, serves as a novel indicator of disease severity and progression in lymphangioleiomyomatosis
CCL14 is a critical regulatory molecule within the LAM microenvironment and a promising biomarker for disease severity and progression.
Authors
- Wenxue Bai (ORCID: https://orcid.org/0009-0006-0111-3607)
- Ni Zhang (ORCID: https://orcid.org/0000-0002-3570-5452)
- Ying Zhou
- Lirong Chen
- Qi Wang
- Min Xie
- Bingyi Liu (ORCID: https://orcid.org/0000-0002-3006-5564)
- Lijuan Hua
- Yi Wang
- Xuezhao Wang
- Mengyao Guo
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1186/s13023-025-04193-2
- Primary Topic
- Tuberous Sclerosis Complex Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00